The Quality and Validity of Publications on Traditional Medicine in the Light of Journalsʹ Policies

Document Type : Opinion

Author

School of Biology, Damghan University, Damghan, Iran.

Abstract

Background
Herbal medicines have a great impact on the pharmaceutical industry and drug discovery. A significant budget and time are spent on herbal research and phytotherapy. However, achievements for the management or treatment of diseases using traditional medicine are not very commensurate with the extensive ongoing herbal research.
Objective
The present article aims to show how Journals' policy can help researchers to improve the quality of their research and so the reproducibility and reliability of published results.
Methodology
The current standards of publications on herbal research common between most Journals publishing biomedical, traditional and herbal research have been examined.
Results
To improve the quality and validity of final publications, journals with herbal related scopes need to consider some criteria in addition to their existing policies. Accordingly, the rule of three has been introduced as the necessary minimum information for publications on herbal research. Rule one focuses on plant identification. The focus of the proposed rules two and three is on the details of materials, methods, and design of herbal research.
Discussion
With the acceptance of the rule of three as critical principles for considering an article for possible publication or rejection, the validity, quality, and reproducibility of literature on traditional medicine and so the speed of natural-based drug development will be improved.

Keywords


1. McNutt M. Reproducibility. Science. 2014 Jan 17;343(6168):229. doi: 10.1126/science.1250475. PMID: 24436391.
2. Holding AN. Novelty in science should not come at the cost of reproducibility. FEBS J. 2019;286(20):3975-3979. doi: 10.1111/febs.14965.
3. Macleod MR. The reproducibility opportunity. Nat Hum Behav. 2018 Sep;2(9):616-617. doi: 10.1038/s41562-018-0398-0. PMID: 31346265.
4- Wittekindt C, Kroll T. Concerning: Subtotal facial nerve decompression in preventing further recurrence and promoting facial nerve recovery of severe idiopathic recurrent facial palsy (Wu SH et al., Eur Arch Otorhinolaryngol. 2015;272(11):3295-8. doi:10.1007/s00405-014-2991-9. Epub 2014 Mar 12). Eur Arch Otorhinolaryngol. 2016 Nov;273(11):4051. doi: 10.1007/s00405-016-4025-2. Epub 2016 Apr 8. PMID: 27059838.
5. Booker A, Johnston D, Heinrich M. Value chains of herbal medicines--research needs and key challenges in the context of ethnopharmacology. J Ethnopharmacol. 2012 Apr 10;140(3):624-33. doi: 10.1016/j.jep.2012.01.039. Epub 2012 Feb 1. PMID: 22326378.
6. Länger R, Stöger E, Kubelka W, Helliwell K. Quality Standards for Herbal Drugs and Herbal Drug Preparations - Appropriate or Improvements Necessary? Planta Med. 2018 Apr;84(6-07):350-360. doi: 10.1055/s-0043-118534. Epub 2017 Aug 29. PMID: 28850958.
7. França TF, Monserrat JM. Reproducibility crisis in science or unrealistic expectations? EMBO Rep. 2018 Jun;19(6):e46008. doi: 10.15252/embr.201846008. Epub 2018 Apr 25. PMID: 29695587; PMCID: PMC5989743.
8. Chan K, Shaw D, Simmonds MS, Leon CJ, Xu Q, Lu A, et al. Good practice in reviewing and publishing studies on herbal medicine, with special emphasis on traditional Chinese medicine and Chinese materia medica. J Ethnopharmacol. 2012 Apr 10;140(3):469-75. doi: 10.1016/j.jep.2012.01.038. Epub 2012 Feb 11. PMID: 22330011.
9. Rezaei A, Farzadfard A, Amirahmadi A, Alemi M, Khademi M. Diabetes mellitus and its management with medicinal plants: A perspective based on Iranian research. J Ethnopharmacol. 2015 Dec 4;175:567-616. doi: 10.1016/j.jep.2015.08.010. Epub 2015 Aug 14. PMID: 26283471.
10. Efferth T, Kaina B. Toxicities by herbal medicines with emphasis to traditional Chinese medicine. Curr Drug Metab. 2011 Dec;12(10):989-96. doi: 10.2174/138920011798062328. PMID: 21892916.
11- Ng SC, Lam YT, Tsoi KK, Chan FK, Sung JJ, Wu JC. Systematic review: the efficacy of herbal therapy in inflammatory bowel disease. Aliment Pharmacol Ther.38(8):854-63. doi: 10.1111/apt.12464. (2013).
12. Cohen BA. How should novelty be valued in science? Elife. 2017 Jul 25;6:e28699. doi: 10.7554/eLife.28699. PMID: 28742499; PMCID: PMC5526661.
13. Winslow LC, Kroll DJ. Herbs as medicines. Arch Intern Med. 1998 Nov 9;158(20):2192-9. doi: 10.1001/archinte.158.20.2192. PMID: 9818799.
14. Manohar N, Adam TJ, Pakhomov SV, Melton GB, Zhang R. Evaluation of Herbal and Dietary Supplement Resource Term Coverage. Stud Health Technol Inform. 2015;216:785-9. PMID: 26262159; PMCID: PMC4801024.
15. Rivera D, Allkin R, Obón C, Alcaraz F, Verpoorte R, Heinrich M. What is in a name? The need for accurate scientific nomenclature for plants. J Ethnopharmacol. 2014 Mar 28;152(3):393-402. doi: 10.1016/j.jep.2013.12.022. Epub 2013 Dec 25. PMID: 24374235.
16. Rezaei A, Fazadfard A, Amirahmadi A. An Encyclopedia of Herb-Disease, a Quick Shortcut for Herbal Research: A Comprehension Based on Iranian Herbal Studies. J Biomedical Sci. 2016, 6:1. doi:10.21767/2254-609X.100054
17. Buckley RC, Arcos DF, Clinciu DL, Scarf D, Trinder M, Santee EJ, et al. Why science? Scientists share their stories. Science. 2017 May 12;356(6338):590-592. doi: 10.1126/science.aan4988. PMID: 28495720.
18. Jäger, AK., and Heinrich M, eds. (2015). Ethnopharmacology (1th ed.). Chichester. Wiley-Blackwell, ISBN: 9781118930731,1118930738,9781118930748,1118930746
19. Kamper SJ. Randomization: Linking Evidence to Practice. J Orthop Sports Phys Ther. 2018 Sep;48(9):730-731. doi: 10.2519/jospt.2018.0704. PMID: 30170525.
20. Goodman SN, Fanelli D, Ioannidis JP. What does research reproducibility mean? Sci Transl Med. 2016 Jun 1;8(341):341ps12. doi: 10.1126/scitranslmed.aaf5027. PMID: 27252173.
21. Matthews HB, Lucier GW, Fisher KD. Medicinal herbs in the United States: research needs. Environ Health Perspect. 1999;107(10):773-778. doi:10.1289/ehp.99107773
22. Lytsy P. P in the right place: Revisiting the evidential value of P-values. J Evid Based Med. 2018 Nov;11(4):288-291. doi: 10.1111/jebm.12319. Epub 2018 Nov 5. PMID: 30398018; PMCID: PMC6587984.
23. Dingledine R. Why Is It so Hard to Do Good Science? [published correction appears in eNeuro. 2018 Nov 8;5(5):]. eNeuro. 2018;5(5):ENEURO.0188-18.2018. Published 2018 Sep 6. doi:10.1523/ENEURO.0188-18.2018
24. Schulz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMC Med. 2010;40:c332. doi: 10.1136/bmj.c332.
25. Ball P. Science must move with the times. Nature. 2019 Nov;575(7781):29-31. doi: 10.1038/d41586-019-03307-8. PMID: 31690868.
26. Bergmann J. Communication: Science is not about simple stories. Nature. 2013 Nov 14;503(7475):198. doi: 10.1038/503198f. PMID: 24226880.
27. Markowetz F. Five selfish reasons to work reproducibly. Genome Biol. 2015 Dec 8;16:274. doi: 10.1186/s13059-015-0850-7. PMID: 26646147; PMCID: PMC4673789.